Although the examples above are mostly in adult cancers, a recent report showed by studying matched primary and recurrent patient samples that c-MYC and MYCN amplifications in combination with p53 defects could also frequently emerge during medulloblastoma recurrence in children [89]. The gene discussed is MYC; the disease is medulloblastoma.